Home/Filings/4/0001178913-24-002391
4//SEC Filing

Toledano Miranda Jayne 4

Accession 0001178913-24-002391

CIK 0001638097other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 4:30 PM ET

Size

7.9 KB

Accession

0001178913-24-002391

Insider Transaction Report

Form 4
Period: 2024-07-31
Toledano Miranda Jayne
DirectorChief Executive Officer
Transactions
  • Award

    Ordinary Shares, par value NIS 0.0000769 per share

    2024-07-31+124,121234,873 total
  • Award

    Stock Option (Right to Buy)

    2024-07-31+500,000500,000 total
    Exercise: $1.99Exp: 2034-04-19Ordinary Shares, par value NIS 0.0000769 per share (500,000 underlying)
Footnotes (2)
  • [F1]Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on April 19, 2024, subject to approval by the Company's shareholders, which was obtained on July 31, 2024. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 19, 2024.
  • [F2]This grant of options was approved by the Board on April 19, 2024, subject to approval by the Company's shareholders, which was obtained on July 31, 2024. The options vest over a three-year period that commenced on April 19, 2024, with a third of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period.

Documents

1 file

Issuer

Entera Bio Ltd.

CIK 0001638097

Entity typeother

Related Parties

1
  • filerCIK 0001686530

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:30 PM ET
Size
7.9 KB